Division of Surgical Oncology

Master
Media Component
The MasSpec Pen is a handheld device that enables surgeons to discriminate between tumor and healthy tissues as they operate.
Heading

Division Highlights

Content
  • The GI Surgery program achieved a 鈥淏est Performing鈥 rank in U.S. News & World Report, and all our eligible procedure and diagnosis areas received the highest applicable rating of 鈥淗igh Performing鈥
  • Surpassed 400 trans-oral thyroid procedures and 100 thyroid ablation procedures, one of the largest such programs in the United States
  • First program in Texas to offer thyroid artery embolization for treatment of thyroid tumors
  • VA program is first in the country to be recognized as National Pancreas Foundation Centers of Excellence
  • Dr. Atif Iqbal launched a first-of-its-kind 鈥淚IT鈥 chemoimmunotherapy trial (NICER trial) for primary colon cancer
  • Launched new endocrine fellowship, offering training in advanced trans-oral thyroid surgery
Media Component
Dr. Ernest Ramsay Camp
Heading

Chief's Message

Content

View a message from the Division of Surgical Oncology Chief, E. Ramsay Camp, M.D.

View Message
Media Component
Surgery Residents Dr. Carter, Dr. Scully and Dr. Mason.
Heading

Education

Content

Our residents are exposed to a broad range of clinical opportunities at a total of six major hospital affiliates. 

Explore Training Programs
Media Component
Scott Holmes, CMI
SNAI1 drives dysfunction of sphingolipid metabolism by activating S1P pathways to amplify TIC self-renewal capacity and RT resistance
Heading

Research

Content

Explore clinical and basic science research from the Division of Surgical Oncology.

Our Research
Media Component
endocrine surgery clinic
Heading

Healthcare

Content

Explore Surgical Oncology healthcare specialty areas from the division.

Healthcare Offerings